COURTNEY ALLEN: Open Payments
NPI 1700340130 · ORANGE CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,457 in 188 payments from 44 companies in 2025. Trend: 2023 $3,482 · 2024 $4,469 · 2025 $4,457
Food & beverage: $3,906Long term medical supply or device loan: $283Education: $268
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 19 | $574 |
| ABBVIE INC. | 9 | $292 |
| AstraZeneca Pharmaceuticals LP | 11 | $283 |
| Janssen Biotech, Inc. | 15 | $281 |
| Merck Sharp & Dohme LLC | 9 | $204 |
| Incyte Corporation | 6 | $183 |
| BeOne Medicines USA, Inc. | 7 | $169 |
| PFIZER INC. | 8 | $169 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $150 |
| Daiichi Sankyo Inc. | 8 | $150 |
Products named: KISQALI, KEYTRUDA, IMFINZI, BRUKINSA, IMBRUVICA, Lenvima, LIBTAYO, Enhertu.
Industry payments across FL — which companies pay providers there.
